Yıl: 2013 Cilt: 14 Sayı: 4 Sayfa Aralığı: 235 - 237 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report

Öz:
In vitro matürasyon (IVM), immatür oositlerin laboratuvar koşullarında olgunlaştırılması için umut vadeden bir tekniktir ve çoğunlukla polikistik over (PKO) tanısı koyulmuş hastalarda konvansiyonel in vitro fertilizas- yon (IVF) tedavisine bir alternatif olarak tercih edilmektedir. Bu raporda, IVF tedavisi sırasında kullanılan gonadotropinlere sürpriz şekilde zayıf over cevabı veren ve aynı siklusu in vitro matürasyon tekniği kullanılarak iptal olmaktan kurtarılan bir vakayı sunuyoruz. Bu vakanın sonucu olarak, IVMin sadece polikistik overli hastalar için değil, aynı zamanda zayıf over cevabı veren hastalar için de iyi bir tedavi seçeneği olabileceği sonucuna vardık. (J Turkish-German Gynecol Assoc 2013; 14: 235-7)
Anahtar Kelime:

Konular: Kadın Hastalıkları ve Doğum

In vitro matürasyon, zayıf over cevabı veren hastalarda in vitro fertilizasyon sikluslarının iptalini engelleyebilir: Vaka raporu

Öz:
In vitro maturation (IVM) is a promising technique that is used forthe maturation of immature oocytes in laboratory conditions andpreferred for use in patients with a diagnosis of polycystic ovary syn-drome (PCOS) as an alternative to conventional in vitro fertilization(IVF) treatment. In this report, we present a case who surprisinglyshowed insufficient response to gonadotrophin stimulation during IVFtreatment and whose cycle was retrieved from cancellation by usingthe in vitro maturation technique. As a result, we conclude that IVM may be a good option not only for PCOS patients, but also for poor responders. (J Turkish-German Gynecol Assoc 2013; 14: 235-7)
Anahtar Kelime:

Konular: Kadın Hastalıkları ve Doğum
Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • Jaroudi KA, Hollanders JM, Sieck UV, Roca GL, El-Nour AM, Coskun S. Pregnancy after transfer of embryos which were generated from in-vitro matured oocytes. Hum Reprod 1997; 12: 857-9. [CrossRef]
  • Son WY, Tan SL. Laboratory and embryological aspects of Hcg- primed in vitro maturation cycles for patients with polycystic ova- ries. Hum Reprod Update. 2010; 16: 675-89. [CrossRef]
  • Fridén B, Hreinsson J, Hovatta O. Birth of a healthy infant after in vitro oocyte maturation and ICSI in a woman with diminished ovar- ian response: case report. Hum Reprod 2005; 20: 2556-8. [CrossRef]
  • Liu J, Lu G, Qian Y, Mao Y, Ding W. Pregnancies and births achieved from in vitro matured oocytes retrieved from poor responders undergoing stimulation in in vitro fertilization cycles. Fertil Steril 2003; 80: 447-9. [CrossRef]
  • McElroy SL, Byrne JA, Chavez SL, Behr B, Hsueh AJ, Westphal LM, et al. Parthenogenic blastocysts derived from cumulus-free in vitro matured human oocytes. PLoS One 2010; 5: e10979. [CrossRef]
  • Son WY, Chung JT, Chian RC, Herrero B, Demirtas E, Elizur S, et al. A 38 h interval between hCG priming and oocyte retrieval increas- es in vivo and in vitro oocyte maturation rate in programmed IVM cycles. Human Reproduction 2008; 23: 2010-6. [CrossRef]
  • Liu J, Katz E, Garcia JE, Compton G, Baramki TA. Successul in vitro maturation of human oocytes not exposed to human chorionic gonadotrophin during ovulation induction, resulting in pregnancy. Fertil Steril 1997; 67: 566-8. [CrossRef]
  • Fadini R, Dal Canto MB, Mignini Renzini M, Brambillasca F, Comi R, Fumagalli D, et al. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective ran- domized study. Reprod Biomed Online 2009; 19: 343-51. [CrossRef]
  • Wynn P, Picton HM, Krapez JA, Rutherford AJ, Balen AH, Gosden RG. Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in-vitro maturation. Hum Reprod 1998; 13: 3132-8. [CrossRef]
  • Lin YH, Hwang JL, Huang LW, Mu SC, Seow KM, Chung J, et al. Combination of FSH priming and HCG priming for in-vitro matura- tion of human oocytes. Hum Reprod 2003; 18: 1632-6. [CrossRef]
  • Suikkari AM, Tulppala M, Tuuri T, Hovatta O, Barnes F. Luteal phase start of low-dose FSH priming of follicles results in an efficient recovery, maturation and fertilization of immature human oocytes. Hum Reprod 2000; 15: 747-51. [CrossRef]
  • Junk SM, Dharmarajan A, Yovich JL. FSH priming improves oocyte maturation, but priming with FSH or Hcg has no effect on subse- quent embryonic development in an in vitro maturation program. Theriogenology 2003; 59: 1741-9. [CrossRef]
  • Chian RC, Gülekli B, Buckett WM, Tan SL. Priming with human chorionic gonadotrophin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome. N Engl J Med 1999; 341: 1624-6. [CrossRef]
  • Lim JH, Yang SH, Xu Y, Yoon SH, Chian RC. Selection of patients for natural cycle in vitro fertilization combined with in vitro maturation of immature oocytes. Fertil Steril 2009; 91: 1050-5. [CrossRef]
APA YALÇINKAYA E, BUDAK Ö, ÇALIIŞKAN E (2013). In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report. , 235 - 237.
Chicago YALÇINKAYA Ender,BUDAK ÖZCAN,ÇALIIŞKAN Eray In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report. (2013): 235 - 237.
MLA YALÇINKAYA Ender,BUDAK ÖZCAN,ÇALIIŞKAN Eray In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report. , 2013, ss.235 - 237.
AMA YALÇINKAYA E,BUDAK Ö,ÇALIIŞKAN E In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report. . 2013; 235 - 237.
Vancouver YALÇINKAYA E,BUDAK Ö,ÇALIIŞKAN E In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report. . 2013; 235 - 237.
IEEE YALÇINKAYA E,BUDAK Ö,ÇALIIŞKAN E "In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report." , ss.235 - 237, 2013.
ISNAD YALÇINKAYA, Ender vd. "In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report". (2013), 235-237.
APA YALÇINKAYA E, BUDAK Ö, ÇALIIŞKAN E (2013). In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report. Journal of the Turkish-German Gynecological Association, 14(4), 235 - 237.
Chicago YALÇINKAYA Ender,BUDAK ÖZCAN,ÇALIIŞKAN Eray In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report. Journal of the Turkish-German Gynecological Association 14, no.4 (2013): 235 - 237.
MLA YALÇINKAYA Ender,BUDAK ÖZCAN,ÇALIIŞKAN Eray In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report. Journal of the Turkish-German Gynecological Association, vol.14, no.4, 2013, ss.235 - 237.
AMA YALÇINKAYA E,BUDAK Ö,ÇALIIŞKAN E In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report. Journal of the Turkish-German Gynecological Association. 2013; 14(4): 235 - 237.
Vancouver YALÇINKAYA E,BUDAK Ö,ÇALIIŞKAN E In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report. Journal of the Turkish-German Gynecological Association. 2013; 14(4): 235 - 237.
IEEE YALÇINKAYA E,BUDAK Ö,ÇALIIŞKAN E "In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report." Journal of the Turkish-German Gynecological Association, 14, ss.235 - 237, 2013.
ISNAD YALÇINKAYA, Ender vd. "In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report". Journal of the Turkish-German Gynecological Association 14/4 (2013), 235-237.